Diabetic Neuropathy Treatment Market
Diabetic Neuropathy Treatment Market Forecasts to 2030 - Global Analysis By Type (Autonomic Neuropathy, Proximal Neuropathy, Focal Neuropathy, Peripheral Neuropathy and Other Types), Treatment, Drug Class, Distribution Channel, End User and By Geography
According to Stratistics MRC, the Global Diabetic Neuropathy Treatment Market is accounted for $4.6 billion in 2023 and is expected to reach $7.6 billion by 2030 growing at a CAGR of 7.5% during the forecast period. Diabetic neuropathy treatment is the various medical interventions and lifestyle modifications aimed at managing the symptoms and complications of neuropathy caused by diabetes. It is a type of nerve damage that can result from prolonged high blood sugar levels associated with diabetes. The treatment approach typically involves a combination of medications, lifestyle changes, and sometimes alternative therapies to alleviate pain, improve nerve function, and prevent further nerve damage.
According to National Diabetes Statistics Report by the Centers for Disease Control and Prevention (CDC), it was found that 34.2 million U.S. individuals (10.5% of the U.S. population) were clinically diagnosed with diabetes in 2018.
Market Dynamics:
Driver:
Rising prevalence of diabetes
With more individuals being diagnosed with diabetes, the demand for effective neuropathy treatments has increased significantly. This trend is driven by factors such as lifestyle changes, aging populations, and heightened awareness leading to early diagnosis. As a result, pharmaceutical companies and healthcare providers are focusing more resources on developing and providing innovative solutions to address diabetic neuropathy. Thus, the market is experiencing a notable surge due to the rising prevalence of diabetes.
Restraint:
Limited efficacy of treatments
Despite advancements, treatments for diabetic neuropathy face challenges, with limited efficacy remaining a significant concern. Current therapies often focus on symptom management rather than addressing the underlying causes. This limitation underscores the need for continued research and innovation in the market to develop more effective strategies that target the root mechanisms of neuropathy in diabetic patients.
Opportunity:
Advancements in treatment
Innovative therapies like nerve decompression surgery, regenerative medicine using stem cells, and targeted drug delivery systems are emerging. Moreover, non-invasive techniques like neurostimulation and wearable tech for continuous monitoring show promise. Precision medicine tailoring treatments to individual genetic profiles is another frontier. These developments signify a shift towards more effective, personalized, and holistic approaches in managing diabetic neuropathy.
Threat:
High cost of treatments
With treatments often priced beyond affordability, access to essential therapies becomes restricted, exacerbating the burden on individuals already grappling with the challenges of managing diabetes-related neuropathy. This financial strain underscores the pressing need for interventions aimed at making these treatments more accessible and affordable to ensure comprehensive care for those affected by diabetic neuropathy. Therefore, the market is plagued by exorbitant costs, creating barriers for patients seeking care.
Covid-19 Impact:
The COVID-19 pandemic significantly impacted the Diabetic Neuropathy Treatment market. Delays in diagnosis and treatment due to healthcare resource reallocation led to worsening patient conditions. Telemedicine gained prominence for consultations, while disruptions in the pharmaceutical supply chain affected medication availability. Clinical trials and research also faced setbacks, slowing down the development of new treatment options.
The focal neuropathy segment is expected to be the largest during the forecast period
The focal neuropathy segment is expected to be the largest during the forecast period. Current therapies include pain management medications, physical therapy, and lifestyle modifications to control blood sugar levels. Emerging treatments such as nerve stimulation techniques and regenerative medicine show promise in addressing underlying nerve damage. However, personalized approaches tailored to individual patient needs remain a key area of research to optimize outcomes in this challenging aspect of diabetic neuropathy management.
The clinics segment is expected to have the highest CAGR during the forecast period
The clinics segment is expected to have the highest CAGR during the forecast period. These clinics provide a range of services, including diagnostic testing, medication management, physical therapy, and lifestyle counseling. They employ skilled healthcare professionals such as neurologists, endocrinologists, and physical therapists who work collaboratively to develop personalized treatment plans. These clinics aim to improve patients' quality of life by managing symptoms, preventing complications, and promoting overall well-being.
Region with largest share:
North America is projected to hold the largest market share during the forecast period. Key players are focusing on developing innovative therapies to address the unmet needs of patients. Additionally, favorable reimbursement policies and healthcare infrastructure are contributing to market expansion. With ongoing research and development activities, the market is poised for continued growth and is expected to offer lucrative opportunities for stakeholders.
Region with highest CAGR:
Asia Pacific is projected to hold the highest CAGR over the forecast period due to various factors such as the increasing prevalence of diabetes. The market offers a range of treatment options for diabetic neuropathy, including medications, physical therapy, nerve stimulation techniques, and lifestyle modifications. Pharmaceutical companies are actively developing new drugs and therapies to address this condition. Technological advancements in medical devices and diagnostics have also contributed to the growth of the market.
Key players in the market
Some of the key players in Diabetic Neuropathy Treatment market include GlaxoSmithKline Plc, Lupin Ltd, Depomed, Inc, Astellas Pharma Inc, Meda Pharma GmBH & Co. KG, Glenmark Pharmaceuticals Ltd., Eli Lilly and Company, Abbott Laboratories, F. Hoffmann-La Roche Ltd, Johnson & Johnson, Pfizer Inc., Novo Nordisk A/S, Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., AbbVie Inc., Novartis AG, Asprius Lifesciences, and Vertex Pharmaceuticals.
Key Developments:
In December 2023, Vertex Pharmaceuticals received FDA approval for CRISPR-based gene editing therapy, a strategy focused on developing and promoting non-opioid pain relievers Based on Vertex's Phase 2 clinical trial results for VX-548, highlighting alternative pain management strategies in diabetic peripheral neuropathy Thiah of the safe and consistent with the search for more effective treatments.
In July 2023, Asprius Lifesciences recently started treating diabetic neuropathy, a disease that causes nerve damage in different parts of the body the company has filed patents for a patented drug combination (FDC), indicating potential for peripheral nerve block.
Types Covered:
• Autonomic Neuropathy
• Proximal Neuropathy
• Focal Neuropathy
• Peripheral Neuropathy
• Other Types
Treatments Covered:
• Slow Progression of Diseases
• Pain Relieving
• Managing Complications
• Physiotherapy
• Drugs
• Other Treatments
Drug Classes Covered:
• Non-Steroidal Anti-Inflammatory Drugs
• Opioid
• Anti-Depressants
• Anti-Seizure
• Other Drug Classes
Distribution Channels Covered:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Specialty Clinics
End Users Covered:
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Homecare Settings
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Diabetic Neuropathy Treatment Market, By Type
5.1 Introduction
5.2 Autonomic Neuropathy
5.3 Proximal Neuropathy
5.4 Focal Neuropathy
5.5 Peripheral Neuropathy
5.6 Other Types
6 Global Diabetic Neuropathy Treatment Market, By Treatment
6.1 Introduction
6.2 Slow Progression of Diseases
6.3 Pain Relieving
6.4 Managing Complications
6.5 Physiotherapy
6.6 Drugs
6.7 Other Treatments
7 Global Diabetic Neuropathy Treatment Market, By Drug Class
7.1 Introduction
7.2 Non-Steroidal Anti-Inflammatory Drugs
7.3 Opioid
7.4 Anti-Depressants
7.5 Anti-Seizure
7.6 Other Drug Classes
8 Global Diabetic Neuropathy Treatment Market, By Distribution Channel
8.1 Introduction
8.2 Hospital Pharmacies
8.3 Retail Pharmacies
8.4 Online Pharmacies
8.5 Specialty Clinics
9 Global Diabetic Neuropathy Treatment Market, By End User
9.1 Introduction
9.2 Hospitals
9.3 Clinics
9.4 Ambulatory Surgical Centers
9.5 Homecare Settings
9.6 Other End Users
10 Global Diabetic Neuropathy Treatment Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 GlaxoSmithKline Plc
12.2 Lupin Ltd
12.3 Depomed, Inc
12.4 Astellas Pharma Inc
12.5 Meda Pharma GmBH & Co. KG
12.6 Glenmark Pharmaceuticals Ltd.
12.7 Eli Lilly and Company
12.8 Abbott Laboratories
12.9 F. Hoffmann-La Roche Ltd
12.10 Johnson & Johnson
12.11 Pfizer Inc.
12.12 Novo Nordisk A/S
12.13 Merck & Co., Inc.
12.14 Teva Pharmaceutical Industries Ltd.
12.15 AbbVie Inc.
12.16 Novartis AG
12.17 Pfizer Inc.
12.18 Vertex Pharmaceuticals
12.19 Asprius Lifesciences
List of Tables
1 Global Diabetic Neuropathy Treatment Market Outlook, By Region (2021-2030) ($MN)
2 Global Diabetic Neuropathy Treatment Market Outlook, By Type (2021-2030) ($MN)
3 Global Diabetic Neuropathy Treatment Market Outlook, By Autonomic Neuropathy (2021-2030) ($MN)
4 Global Diabetic Neuropathy Treatment Market Outlook, By Proximal Neuropathy (2021-2030) ($MN)
5 Global Diabetic Neuropathy Treatment Market Outlook, By Focal Neuropathy (2021-2030) ($MN)
6 Global Diabetic Neuropathy Treatment Market Outlook, By Peripheral Neuropathy (2021-2030) ($MN)
7 Global Diabetic Neuropathy Treatment Market Outlook, By Other Types (2021-2030) ($MN)
8 Global Diabetic Neuropathy Treatment Market Outlook, By Treatment (2021-2030) ($MN)
9 Global Diabetic Neuropathy Treatment Market Outlook, By Slow Progression of Diseases (2021-2030) ($MN)
10 Global Diabetic Neuropathy Treatment Market Outlook, By Pain Relieving (2021-2030) ($MN)
11 Global Diabetic Neuropathy Treatment Market Outlook, By Managing Complications (2021-2030) ($MN)
12 Global Diabetic Neuropathy Treatment Market Outlook, By Physiotherapy (2021-2030) ($MN)
13 Global Diabetic Neuropathy Treatment Market Outlook, By Drugs (2021-2030) ($MN)
14 Global Diabetic Neuropathy Treatment Market Outlook, By Other Treatments (2021-2030) ($MN)
15 Global Diabetic Neuropathy Treatment Market Outlook, By Drug Class (2021-2030) ($MN)
16 Global Diabetic Neuropathy Treatment Market Outlook, By Non-Steroidal Anti-Inflammatory Drugs (2021-2030) ($MN)
17 Global Diabetic Neuropathy Treatment Market Outlook, By Opioid (2021-2030) ($MN)
18 Global Diabetic Neuropathy Treatment Market Outlook, By Anti-Depressants (2021-2030) ($MN)
19 Global Diabetic Neuropathy Treatment Market Outlook, By Anti-Seizure (2021-2030) ($MN)
20 Global Diabetic Neuropathy Treatment Market Outlook, By Other Drug Classes (2021-2030) ($MN)
21 Global Diabetic Neuropathy Treatment Market Outlook, By Distribution Channel (2021-2030) ($MN)
22 Global Diabetic Neuropathy Treatment Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
23 Global Diabetic Neuropathy Treatment Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
24 Global Diabetic Neuropathy Treatment Market Outlook, By Online Pharmacies (2021-2030) ($MN)
25 Global Diabetic Neuropathy Treatment Market Outlook, By Specialty Clinics (2021-2030) ($MN)
26 Global Diabetic Neuropathy Treatment Market Outlook, By End User (2021-2030) ($MN)
27 Global Diabetic Neuropathy Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
28 Global Diabetic Neuropathy Treatment Market Outlook, By Clinics (2021-2030) ($MN)
29 Global Diabetic Neuropathy Treatment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
30 Global Diabetic Neuropathy Treatment Market Outlook, By Homecare Settings (2021-2030) ($MN)
31 Global Diabetic Neuropathy Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
